Discover December 2024's Top Penny Stocks On The UK Exchange

The UK market has recently faced challenges, with the FTSE 100 index experiencing a decline due to weak trade data from China, highlighting global economic interdependencies. Despite these broader market fluctuations, investors often seek opportunities in penny stocks—an area that remains relevant for its potential to combine affordability with growth prospects. These smaller or newer companies can offer unique investment opportunities when backed by strong financials and fundamentals.

Top 10 Penny Stocks In The United Kingdom

Name	Share Price	Market Cap	Financial Health Rating
ME Group International (LSE:MEGP)	£2.065	£778.02M	★★★★★★
Begbies Traynor Group (AIM:BEG)	£0.94	£148.28M	★★★★★★
Secure Trust Bank (LSE:STB)	£3.48	£66.37M	★★★★☆☆
Ultimate Products (LSE:ULTP)	£1.155	£98.68M	★★★★★★
Luceco (LSE:LUCE)	£1.26	£194.33M	★★★★★☆
Stelrad Group (LSE:SRAD)	£1.34	£170.65M	★★★★★☆
Next 15 Group (AIM:NFG)	£3.925	£390.36M	★★★★☆☆
Integrated Diagnostics Holdings (LSE:IDHC)	$0.433	$251.71M	★★★★★★
Tristel (AIM:TSTL)	£3.875	£184.81M	★★★★★★
Impax Asset Management Group (AIM:IPX)	£2.30	£293.88M	★★★★★★

Click here to see the full list of 468 stocks from our UK Penny Stocks screener.

Here's a peek at a few of the choices from the screener.

Surgical Innovations Group (AIM:SUN)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Surgical Innovations Group plc designs, manufactures, and exports medical products for laparoscopic and robotic minimally invasive surgery across the UK, Europe, Asia Pacific, the US, and internationally with a market cap of £5.13 million.

Operations: The company's revenue is generated from three primary segments: SI Brand (£6.39 million), Distribution (£3.88 million), and OEM including Precision Engineering (£2.26 million).

Market Cap: £5.13M

Surgical Innovations Group plc, with a market cap of £5.13 million, has shown modest revenue growth in its recent earnings report, generating £6.18 million for the half year ended June 30, 2024. Despite this increase from the previous year, the company remains unprofitable with a net loss of £0.487 million. The debt to equity ratio is satisfactory at 4.8%, and short-term assets exceed liabilities by a comfortable margin (£6M vs £3.1M). However, it faces challenges with less than one year of cash runway and high share price volatility over recent months despite stable weekly volatility compared to other UK stocks.

• Take a closer look at Surgical Innovations Group's potential here in our financial health report.
• Evaluate Surgical Innovations Group's historical performance by accessing our past performance report.

Westminster Group (AIM:WSG)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Westminster Group PLC is a specialist security and services company that designs and supplies technology security solutions and services globally, with a market cap of £5.78 million.

Operations: The company's revenue is derived from Technology (£1.20 million) and Managed Services, including Managed Services Guarding (£4.83 million).

Market Cap: £5.78M

Westminster Group PLC, with a market cap of £5.78 million, faces challenges as it remains unprofitable, reporting a net loss of £4.25 million for the eighteen months ended June 30, 2024. The company has undertaken a strategic review to address share-price concerns and improve shareholder value. Despite its financial struggles, Westminster secured several significant contracts worth over $1.2 million annually with an international services organization and maintains sufficient cash runway for more than a year based on current free cash flow levels. Its debt level is satisfactory with short-term assets exceeding liabilities comfortably.

• Navigate through the intricacies of Westminster Group with our comprehensive balance sheet health report here.
• Review our historical performance report to gain insights into Westminster Group's track record.

Worldsec (LSE:WSL)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Worldsec Limited is a closed-ended investment company focusing on small and medium-sized trading companies in the Greater China and South East Asian regions, with a market cap of £1.06 million.

Operations: The company's revenue segment is derived from its investment holding activities, which reported a revenue of -$0.21 million.

Market Cap: £1.06M

Worldsec Limited, with a market cap of £1.06 million, focuses on investments in small and medium-sized enterprises in Greater China and South East Asia. The company is pre-revenue, reporting minimal sales of US$0.048 million for the first half of 2024 and a net loss of US$0.146 million compared to a profit the previous year. Despite its unprofitability, Worldsec is debt-free with short-term assets significantly exceeding liabilities, providing financial stability. The board's extensive experience supports strategic decision-making while maintaining shareholder value without dilution over the past year. Worldsec has sufficient cash runway for over three years under current conditions.

• Jump into the full analysis health report here for a deeper understanding of Worldsec.
• Assess Worldsec's previous results with our detailed historical performance reports.

Summing It All Up

• Embark on your investment journey to our 468 UK Penny Stocks selection here.
• Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
• Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Looking For Alternative Opportunities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com